Assessment and treatment of endothelial dysfunction in humans

Journal of the American College of Cardiology

Volumn 34, Issue 3, 1999, Pages 631-638

  Anderson, Todd J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; DEFEROXAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; GLUTATHIONE; LOW DENSITY LIPOPROTEIN; MEDROXYPROGESTERONE; MEVINOLIN; NITRIC OXIDE; PROBUCOL; PROGESTERONE; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; ENDOTHELIUM INJURY; ESTROGEN THERAPY; EXERCISE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; VASCULAR ENDOTHELIUM;

EID: 0032869042     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00259-4     Document Type: Article

References (110)

1. Moncada S., Higgs A. The L-arginine-NO pathway. N Engl J Med. 329:1993;2002-2012.
2. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
3. Furchgott R.F., Zawadski J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
4. Dzau V.J., Burt D.W., Pratt R.E. Molecular biology to the renin-angiotensin system. Am J Physiol. 255:1988;F563-F573.
5. Rees D.D., Palmer R.M.J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 86:1989;3375-3378.
6. Quyyumi A.A., Dakak N., Andrews N.P., et al. Nitric oxide activity in the human coronary circulation. J Clin Invest. 95:1995;1747-1755.
7. Haynes W.G., Ferro C.J., O'Kane K.P.J., Somerville D., Lomax C.C., Webb D.J. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation. 93:1996;1860-1870.
8. Sudhir K., MacGregor J.S., Gupta M., et al. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo intravascular two-dimensional and doppler ultrasound studies . Circulation. 87:1993;931-938.
9. Duffy S.J., Tran B.T., New G., et al. Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans. Am J Physiol. 274:1998;78-83.
10. Gordon J.B., Ganz P., Nabel E.G., et al. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest. 83:1989;1946-1952.
11. Zeiher A.M., Drexler H., Wollschlaeger H., Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation. 84:1991;1984-1992.
12. Goodhart D.M., Anderson T.J. Coronary arterial vasomotion the role of nitric oxide and the influence of coronary atherosclerosis and its risks . Am J Cardiol. 82:1998;1034-1039.
13. Quyyumi A.A., Dakak N., Andrews N.P., Gilligan D.M., Panza J.A., Cannon R.O. III. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 92:1995;320-326.
14. Libby P. Molecular basis of the acute coronary syndromes. Circulation. 92:1995;657-671.
15. Luscinskas F.W., Gimbrone M.A. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med. 47:1996;413-421.
16. Crea F, Biasucci LM, Buffon A, et al. Role of inflammation in the pathogenesis of unstable coronary artery disease. Am J Cardiol 1997;80 Suppl:10-6E.
17. Barnes P.J., Karin M. Nuclear factor-KB-A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 336:1997;1066-1071.
18. Kubes P., Suzuki M., Granger D.N. Nitric oxide an endogenous modulator of leukocyte adhesion . Proc Natl Acad Sci USA. 88:1991;4651-4655.
19. Davi G., Romano M., Mezzetti A., et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation. 97:1998;953-957.
20. Ridker P.M., Hennekens C., Roitman-Johnson B., Stampfer M.J., Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 351:1998;88-92.
21. Radomski M.W., Palmer R.M.J., Moncada S. The anti-aggregating properties of vascular endothelium interactions between prostacyclin and nitric oxide . Br J Pharmacol. 92:1987;639-646.
22. Michelson A.D., Benoit S.E., Furman M.I., et al. Effects of endothelium-derived relaxing factor/nitric oxide on platelet surface glycoproteins. Am J Physiol. 270:1996;H1640-H1648.
23. Diodati J.G., Dakak N., Gilligan D.M., Quyyumi A.A. Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. Circulation. 98:1998;17-24.
24. Xiao Z., Theroux P. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation. 97:1998;251-256.
25. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;949-955.
26. Gawaz M., Neumann F.J., Dickfeld T., et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation. 98:1998;1164-1171.
27. Freedman J.E., Ting B., Hankin B., Loscalzo J., Keaney J.F.J., Vita J.A. Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. Circulation. 98:1998;1481-1486.
28. Golino P., Piscione F., Willerson J.T., et al. Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med. 324:1991;641-648.
29. Zeiher A.M., Drexler H., Wollschlager H., Just H. Modulation of coronary vasomotor tone in humans progressive endothelial dysfunction with different early stages of coronary atherosclerosis . Circulation. 83:1991;391-401.
30. Doucette J.W., Corl P.D., Payne H.M., et al. Validation of a doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 85:1992;1899-1911.
31. Gould K.L., Martucci J.P., Goldberg D.I., et al. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation. 89:1994;1530-1538.
32. Aengevaeren W.R.M., Uijen G.J.H., Jukema J.W., Bruschke A.V.G., van der Werf T. Functional evaluation of lipid lowering therapy by pravastatin in the regression growth evaluation statin study (REGRESS). Circulation. 96:1997;429-435.
33. Uren N.G., Melin J.A., de Bruyne B., Wijns W., Baudhuin T., Camici P.G. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med. 330:1994;1782-1788.
34. Uren N.G., Crake T., Lefroy D.C., de Silva R., Davies G.J., Maseri A. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol. 21:1993;612-621.
35. Parodi O., Neglia D., Palombo C., et al. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. Circulation. 96:1997;864-873.
36. Hokanson D.E., Sumner D.S., Strandness D.E.J. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng. 22:1975;25-29.
37. Creager M.A., Cooke J.P., Mendelsohn M.E., et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 86:1990;228-234.
38. Panza J.A., Quyyumi A.A., Brush J.E. Jr, Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:1990;22-27.
39. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
40. Sorensen K.E., Celermajer D.S., Spiegelhalter D.J., et al. Non-invasive measurement of human endothelium dependent arterial responses accuracy and reproducibility . Br H J. 74:1995;247-253.
41. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relationship of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26:1995;1235-1241.
42. Zarnke K.B., Feldman R.D. Direct angiotensin converting enzyme inhibitor-mediated venodilation. Clin Pharmacol Ther. 59:1996;559-568.
43. Cines D.B., Pollak E.S., Buck C.A., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 91:1998;3527-3561.
44. Baron A.D. Insulin and the vasculature old actors, new roles . [review]. J Invest Med. 44:1996;406-412.
45. Panza J.A. Endothelial dysfunction in essential hypertension. [review]. Clin Cardiol. 20:(Suppl):1997;33-40.
46. Anderson T.J. Oxidative stress, endothelial function and coronary atherosclerosis. Cardiologia. 42:1997;701-714.
47. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990's . Nature. 362:1993;801-809.
48. Oemar B.S., Tschudi M.R., Godoy N., Brovkovich V., Malinkski T., Luscher T. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation. 97:1998;2494-2498.
49. Farhy R.D., Carretero O.A., Ho K.-L., Scicli A.G. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res. 72:1993;1202-1210.
50. Hasdai D., Holmes D.R. Jr, Garratt K.N., Edwards W.D., Lerman A. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation. 95:1997;357-362.
51. Reddy K.G., Nair R.N., Sheehan H.M., Hodgson J.M. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 23:1994;833-843.
52. Anderson TJ, Gerhard MD, Meredith IT, et al. Systemic nature of endothelial dysfunction in atherosclerosis. [Review]. Am J Cardiol 1995;75 Suppl:71-4B.
53. Steinberg D. Antioxidants and atherosclerosis a current assessment . Circulation. 84:1991;1420-1425.
54. Kugiyama K., Ohgushi M., Sugiyama S., et al. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 71:1992;1422-1428.
55. Ohgushi M., Kugiyama K., Fukunaga K., et al. Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. Arterioscler Thromb. 13:1993;1525-1532.
56. Liao J.K., Clark S.L. Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest. 95:1995;1457-1463.
57. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 250:1986;H822-H827.
58. Boulanger C.M., Tanner F.C., Bea M.L., Hahn A.W., Werner A., Luscher T.F. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res. 70:1992;1191-1197.
59. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 281:1992;627-630.
60. Stroes E., Kastelein J., Erkelens W., et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest. 99:1997;41-46.
61. Lerman A., Webster M.W.I., Chesebro J.H., et al. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation. 88:1993;2923-2928.
62. Tsao P.S., Niebauer J., Buitrago R., et al. Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arterioscler Thromb Vasc Biol. 18:1998;947-953.
63. Anderson T.J., Meredith I.T., Charbonneau F., et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation. 93:1996;1647-1650.
64. Heitzer T., Yla-Herttuala S., Luoma J., et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia role of oxidized LDL . Circulation. 93:1996;1346-1353.
65. Plotnick G.D., Corretti M.C., Vogel R.A. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA. 278:1997;1682-1686.
66. Steinberg H.O., Tarshoby M., Monestel R., et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 100:1997;1230-1239.
67. Williams S.B., Goldfine A.B., Timimi F.K., et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 97:1998;1695-1701.
68. Johnstone M., Creager S.J., Scales K., Cusco J.A., Lee B., Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:1993;2510-2516.
69. Celermajer D.S., Sorensen K.E., Georgakopoulos D., et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:(Pt 1):1993;2149-2155.
70. Celermajer D.S., Adams M.R., Clarkson P., et al. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults. N Engl J Med. 334:1996;150-154.
71. Celermajer D.S., Sorensen K., Ryalls M., et al. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol. 22:1993;854-858.
72. Anderson T.J., Meredith I.T., Uehata A., et al. Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation. Circulation. 88:1993;1093-1100.
73. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
74. Ohara Y., Peterson T.E., Sayegh H.S., Subramanian R.R., Wilcox J.N., Harrison D.G. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation. 92:1995;898-903.
75. Harrison D.G., Armstrong M.L., Freiman P.C., Heistad D.D. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 80:1987;1808-1811.
76. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. [see comments]. N Engl J Med. 332:1995;488-493.
77. Tamai O., Matsuoka H., Itabe H., Wada Y., Kohno K., Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation. 95:1997;76-82.
78. Leung W.H., Lau C.P., Wong C.K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 341:1993;1496-1500.
79. Keaney J.F. Jr, Xu A., Cunningham D., Jackson T., Frei B., Vita J.A. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest. 95:1995;2520-2529.
80. Keaney J.F. Jr, Gaziano J.M., Xu A., et al. Low-dose alpha tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest. 93:1994;844-851.
81. Ting H.H., Timimi F.K., Haley E.A., Roddy M., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 95:1997;2617-2622.
82. Heitzer T., Just H., Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 94:1996;6-9.
83. Levine G.N., Frei B., Koulouris S.N., Gerhard M.D., Keaney J.F. Jr, Vita J.A. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 93:1996;1107-1113.
84. Solzbach U., Hornig B., Jeserich M., Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 96:1997;1513-1519.
85. Jialal I., Fuller C.J., Huet B.A. The effect of alpha-tocopherol supplementation on LDL oxidation a dose-response study . Arterioscler Thromb Vasc Biol. 15:1995;190-198.
86. Gilligan D.M., Sack M.N., Guetta V., et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol. 24:1994;1611-1617.
87. Elliott T.G., Barth J.D., Mancini G.B.J. Effects of vitamin E on endothelial function in men after myocardial infarction. Am J Cardiol. 76:1995;1188-1190.
88. Rajagopalan S., Kurz S., Munzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 97:1996;1916-1923.
89. Finta K.M., Fischer M.J., Lee L., Gordon D., Pitt B., Webb R.C. Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet. Atherosclerosis. 100:1993;149-156.
90. Hornig B., Kohler C., Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation. 95:1997;1115-1118.
91. Antony I., Lerebours G., Nitenberg A. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. Circulation. 94:1996;3115-3122.
92. Mancini G.B.J., Henry G.C., Macaya C., et al. Angiotensin converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease The TREND study . Circulation. 94:1996;258-265.
93. Lyons D., Webster J., Benjamin N. Effect of enalapril and quinapril on forearm vascular ACE in man. Eur J Clin Pharmacol. 51:1997;373-378.
94. Anderson T.J., Overhiser R.W., Haber H.E., Charbonneau F. A comparative study of four anti-hypertensive agents on endothelial function in patients with coronary disease. J Am Coll Cardiol. 31:1998;327. (abstr).
95. Mullen M.J., Clarkson P., Donald A.E., et al. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients a randomized,double-blind study . J Am Coll Cardiol. 31:1998;1330-1335.
96. Taddei S., Virdis A., Ghiadoni L., Mattei P., Salvetti A. Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients. J Hypertens. 16:1998;447-456.
97. Williams J.K., Honore E.K., Washburn S.A., Clarkson T.B. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 24:1994;1757-1761.
98. Collins P., Shay J., Jiang C., Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation. 90:1994;1964-1968.
99. Sack M.N., Rader D.J., Cannon R.O. III. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 343:1994;269-270.
100. Gilligan D.M., Quyyumi A.A., Cannon R.O. III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 89:1994;2545-2551.
101. Reis S.E., Gloth S.T., Blumenthal R.S., et al. Ehinyl estradiol acutely attenuated abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:1994;52-60.
102. Anderson T.J. Acute effect of estrogen on metabolic coronary vasodilator responses to atrial pacing in post-menopausal women. Am J Cardiol. 82:1998;236-239.
103. Guetta V., Quyyumi A.A., Prasad A., Panza J.A., Maclawiw M., Cannon R.O. III. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation. 96:1997;2795-2801.
104. Lieberman E.H., Gerhard M.D., Uehata A., et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 121:1994;936-941.
105. Gerhard M., Walsh B.W., Tawakol A., et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation. 98:1998;1158-1163.
106. Adams M.R., Register T.C., Golden D.L., Wagner J.D., Williams J.K. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;217-221.
107. Creager M.A., Gallagher S.J., Girerd X.J., Coleman S.M., Dzau V.J., Cooke J.P. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 90:1992;1248-1253.
108. Clarkson P., Adams M.R., Powe A.J., et al. Oral l-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 97:1996;1989-1994.
109. Quyyumi A.A. Does acute improvement in endothelial dysfunction in coronary artery disease improve myocardial ischemia? J Am Coll Cardiol. 32:1998;904-911.
110. Davis S.F., Yeung A.C., Meredith I.T., et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation. 93:1996;457-463.